Fundraising Fox
🦊/People
Sign in

Kevin Lalande

Investor

Managing Director at Sante Ventures · Board director at Molecular Templates · Board director at ChanRx · Board director at Hospitalists Now

Austin, Texas

Writes $100K – $5M checks · typically $1.5M

Find your path to Kevin

1,257 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.

Deep NisharunlockedKevin: together at Stanford University (2017–2018)
×3Kevin: together at Stanford University
×6Kevin: together at Harvard Business School
×2Kevin: together at McKinsey & Company

About

Kevin Lalande, a repeat founder and founding MD/CIO, is unusually hands-on in portfolio strategy, blending technical AI fluency with a focus on platform companies that change drug discovery risk-reward.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechEnterprise SoftwareHealthtechMedical Devices

Board director at Molecular Templates

Intro paths

→

In turn, Kevin can intro founders to Molecular Templates's investors below.

Molecular Templates's investors · 2

Excel Venture ManagementBoston · $1M – $5M checksSante Health VenturesAustin · since 2023

Co-founders at Molecular Templates

EE
Eric E. PomaExecutive Officer, Director

Board director at ChanRx

Intro paths

→

In turn, Kevin can intro founders to ChanRx's investors below.

ChanRx's investors · 3

Frazier Life SciencesPalo Alto · since 2015Jumpstart VenturesCleveland · $500K – $2M checksSante Health VenturesAustin · since 2015

Co-founders at ChanRx

AB
Arthur BrownExecutive Officer, Director

Board director at Hospitalists Now

Intro paths

→

In turn, Kevin can intro founders to Hospitalists Now's investors below.

Hospitalists Now's investors · 1

Sante Health VenturesAustin · since 2015

Experience

  1. SANTÉManaging Directorcurrent2007 — present
  2. Austin VenturesPrincipal2000 — 2007
  3. McKinsey & CompanyBusiness Analyst1997 — 1999

Skills & more

Venture CapitalPrivate EquityInvestmentsEntrepreneurshipMedical DevicesStart-upsHealthcareManagementStrategic PartnershipsCorporate DevelopmentM&A experienceFinance
+12 moreBusiness StrategyDue DiligenceCompetitive AnalysisCorporate FinanceMergers & AcquisitionsCommercializationStrategyFinancial ModelingBusiness DevelopmentAngel InvestingBiotechnologyLifesciences

From Kevin's professional profile.

Colleagues at Sante Ventures

Alana Horowitz
Senior Associate at Sante Ventures
Allie Knauer
Venture Fellow at Sante Ventures
Ashley Seehusen
Venture Partner at Sante Ventures
Auriel August
Principal at Sante Ventures
Auriel August, MD
Principal at Sante Ventures
Brendan Boland
Venture Fellow at Sante Ventures
Brooke Jones
Head of Capital Formation at Sante Ventures
Casey Cunningham
Partner and Chief Scientific Officer at Sante Ventures

Network3

Auriel August
Principal at Sante Ventures
Derek Dedeker
Principal at Frist Cressey Ventures
Eric Epstein
Partner at Healthier Capital

Investors connected to Kevin in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kevin Lalande?
Kevin Lalande, a repeat founder and founding MD/CIO, is unusually hands-on in portfolio strategy, blending technical AI fluency with a focus on platform companies that change drug discovery risk-reward.
Where does Kevin Lalande work?
Kevin Lalande is Managing Director at Sante Ventures and Board director at Molecular Templates and Board director at ChanRx and Board director at Hospitalists Now.
What does Kevin Lalande invest in?
Kevin Lalande invests in AI & Machine Learning, Biotech, Enterprise Software, Healthtech, Medical Devices.
What check size does Kevin Lalande write?
Kevin Lalande typically writes checks of $100K – $5M.
Where did Kevin Lalande go to school?
Kevin Lalande studied at Harvard Business School (MBA, MBA); Stanford University (Graduate Certificate, Artificial Intelligence).

Same school

Shared employers